Keith Crandell - 12 Aug 2021 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Director
Signature
/s/ Mark McDonnell as Attorney-in-Fact for Keith Crandell
Issuer symbol
TWST
Transactions as of
12 Aug 2021
Net transactions value
-$4,815,377
Form type
4
Filing time
13 Aug 2021, 18:35:30 UTC
Previous filing
09 Aug 2021
Next filing
05 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Sale $150,985 -1,412 -74% $106.93 486 12 Aug 2021 Direct
transaction TWST Common Stock Sale $4,389,567 -41,033 -34% $106.98 78,602 12 Aug 2021 By Keith L. Crandell Trust F6
transaction TWST Common Stock Sale $274,826 -2,555 -3.3% $107.56 76,047 12 Aug 2021 By Keith L. Crandell Trust F7
transaction TWST Common Stock Other $0 -286,480 -39% $0.000000 440,354 11 Feb 2021 By Arch Venture Fund VII, L.P. F1, F2, F4, F5
transaction TWST Common Stock Other $0 +14,560 +18% $0.000000 97,252 11 Feb 2021 By Keith L. Crandell Trust F1, F5
transaction TWST Common Stock Other $0 -113,520 -39% $0.000000 174,584 11 Feb 2021 By ARCH Venture Fund VIII Overage, L.P. F1, F3, F4, F5
transaction TWST Common Stock Other $0 +1 +0% $0.000000 97,253 11 Feb 2021 By Keith L. Crandell Trust F1, F5
transaction TWST Common Stock Other $0 -214,828 -49% $0.000000 225,526 13 May 2021 By ARCH Venture Fund VII, L.P. F1, F2, F4, F5
transaction TWST Common Stock Other $0 +10,918 +11% $0.000000 108,171 13 May 2021 By Keith L. Crandell Trust F1, F5
transaction TWST Common Stock Other $0 -85,172 -49% $0.000000 89,412 13 May 2021 By ARCH Venture Fund VIII Overage, L.P. F1, F3, F4, F5
transaction TWST Common Stock Other $0 +1 +0% $0.000000 108,172 13 May 2021 By Keith L. Crandell Trust F1, F5
transaction TWST Common Stock Other $0 -225,526 -100% $0.000000* 0 19 May 2021 By ARCH Venture Fund VII, L.P. F1, F2, F4, F5
transaction TWST Common Stock Other $0 +11,462 +11% $0.000000 119,634 19 May 2021 By Keith L. Crandell Trust F1, F5
transaction TWST Common Stock Other $0 -89,412 -100% $0.000000* 0 19 May 2021 By ARCH Venture Fund VIII Overage, L.P. F1, F3, F4, F5
transaction TWST Common Stock Other $0 +1 +0% $0.000000 119,635 19 May 2021 By Keith L. Crandell Trust F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro-rata distribution of Common Stock held by a limited partnership to its partners for no consideration.
F2 The shares were directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
F3 The shares were directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("ARCH VIII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
F4 Keith Crandell is a managing director of ARCH VII LLC and ARCH VIII LLC, and may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Mr. Crandell disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
F5 Change in form of ownership of shares previously reported as beneficially owned by the reporting person.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.39 to $107.37. The reporting person undertakes to provide to TWST, any security holder of TWST, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) and (7) to this Form 4.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.405 to $107.70.